269 related articles for article (PubMed ID: 8641809)
1. Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant.
Di Tommaso A; Saletti G; Pizza M; Rappuoli R; Dougan G; Abrignani S; Douce G; De Magistris MT
Infect Immun; 1996 Mar; 64(3):974-9. PubMed ID: 8641809
[TBL] [Abstract][Full Text] [Related]
2. Mucosal immunoadjuvant activity of recombinant Escherichia coli heat-labile enterotoxin and its B subunit: induction of systemic IgG and secretory IgA responses in mice by intranasal immunization with influenza virus surface antigen.
Verweij WR; de Haan L; Holtrop M; Agsteribbe E; Brands R; van Scharrenburg GJ; Wilschut J
Vaccine; 1998 Dec; 16(20):2069-76. PubMed ID: 9796066
[TBL] [Abstract][Full Text] [Related]
3. Intranasal immunization with influenza vaccine and a detoxified mutant of heat labile enterotoxin from Escherichia coli (LTK63).
Pine S; Barackman J; Ott G; O'Hagan D
J Control Release; 2002 Dec; 85(1-3):263-70. PubMed ID: 12480330
[TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of the mucosal adjuvanticity of the type II heat-labile enterotoxins LT-IIa and LT-IIb.
Martin M; Metzger DJ; Michalek SM; Connell TD; Russell MW
Infect Immun; 2000 Jan; 68(1):281-7. PubMed ID: 10603399
[TBL] [Abstract][Full Text] [Related]
5. Intranasal immunization with SAG1 and nontoxic mutant heat-labile enterotoxins protects mice against Toxoplasma gondii.
Bonenfant C; Dimier-Poisson I; Velge-Roussel F; Buzoni-Gatel D; Del Giudice G; Rappuoli R; Bout D
Infect Immun; 2001 Mar; 69(3):1605-12. PubMed ID: 11179334
[TBL] [Abstract][Full Text] [Related]
6. Potency of a genetically detoxified mucosal adjuvant derived from the heat-labile enterotoxin of Escherichia coli (LTK63) is not adversely affected by the presence of preexisting immunity to the adjuvant.
Ugozzoli M; Santos G; Donnelly J; O'Hagan DT
J Infect Dis; 2001 Jan; 183(2):351-354. PubMed ID: 11110644
[TBL] [Abstract][Full Text] [Related]
7. Immunization onto bare skin with heat-labile enterotoxin of Escherichia coli enhances immune responses to coadministered protein and peptide antigens and protects mice against lethal toxin challenge.
Beignon AS; Briand JP; Muller S; Partidos CD
Immunology; 2001 Mar; 102(3):344-51. PubMed ID: 11298834
[TBL] [Abstract][Full Text] [Related]
8. The mucosal adjuvanticity of two nontoxic mutants of Escherichia coli heat-labile enterotoxin varies with immunization routes.
Park EJ; Chang JH; Kim JS; Yum JS; Chung SI
Exp Mol Med; 2000 Jun; 32(2):72-8. PubMed ID: 10926118
[TBL] [Abstract][Full Text] [Related]
9. Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells.
Ryan EJ; McNeela E; Murphy GA; Stewart H; O'hagan D; Pizza M; Rappuoli R; Mills KH
Infect Immun; 1999 Dec; 67(12):6270-80. PubMed ID: 10569737
[TBL] [Abstract][Full Text] [Related]
10. Levels of expression and immunogenicity of attenuated Salmonella enterica serovar typhimurium strains expressing Escherichia coli mutant heat-labile enterotoxin.
Covone MG; Brocchi M; Palla E; Dias da Silveira W; Rappuoli R; Galeotti CL
Infect Immun; 1998 Jan; 66(1):224-31. PubMed ID: 9423862
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the adjuvant effect of Escherichia coli heat-labile enterotoxin mutant (LTK63) on the systemic immune responses to intranasally co-administered measles virus nucleoprotein. Part I: antibody responses.
Erume J; Partidos H
Afr Health Sci; 2001 Aug; 1(1):3-8. PubMed ID: 12789125
[TBL] [Abstract][Full Text] [Related]
12. Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat-labile enterotoxin.
De Haan L; Holtrop M; Verweij WR; Agsteribbe E; Wilschut J
Immunology; 1999 Aug; 97(4):706-13. PubMed ID: 10457227
[TBL] [Abstract][Full Text] [Related]
13. Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers.
Stephenson I; Zambon MC; Rudin A; Colegate A; Podda A; Bugarini R; Del Giudice G; Minutello A; Bonnington S; Holmgren J; Mills KH; Nicholson KG
J Virol; 2006 May; 80(10):4962-70. PubMed ID: 16641287
[TBL] [Abstract][Full Text] [Related]
14. Heat-labile enterotoxin of Escherichia coli and its site-directed mutant LTK63 enhance the proliferative and cytotoxic T-cell responses to intranasally co-immunized synthetic peptides.
Partidos CD; Salani BF; Pizza M; Rappuoli R
Immunol Lett; 1999 Apr; 67(3):209-16. PubMed ID: 10369128
[TBL] [Abstract][Full Text] [Related]
15. Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit.
de Haan L; Holtrop M; Verweij WR; Agsteribbe E; Wilschut J
Vaccine; 1996 Mar; 14(4):260-6. PubMed ID: 8744549
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the LTK63 adjuvant effect on cellular immune responses to measles virus nucleoprotein.
Erume J; Partidos CD
Afr Health Sci; 2011 Jun; 11(2):151-7. PubMed ID: 21857843
[TBL] [Abstract][Full Text] [Related]
17. Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice.
Amuguni JH; Lee S; Kerstein KO; Brown DW; Belitsky BR; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
Vaccine; 2011 Jun; 29(29-30):4778-84. PubMed ID: 21565244
[TBL] [Abstract][Full Text] [Related]
18. Recombinant Norwalk virus-like particles administered intranasally to mice induce systemic and mucosal (fecal and vaginal) immune responses.
Guerrero RA; Ball JM; Krater SS; Pacheco SE; Clements JD; Estes MK
J Virol; 2001 Oct; 75(20):9713-22. PubMed ID: 11559804
[TBL] [Abstract][Full Text] [Related]
19. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections.
Jakobsen H; Schulz D; Pizza M; Rappuoli R; Jónsdóttir I
Infect Immun; 1999 Nov; 67(11):5892-7. PubMed ID: 10531245
[TBL] [Abstract][Full Text] [Related]
20. Transcutaneous immunization with tetanus toxoid and mutants of Escherichia coli heat-labile enterotoxin as adjuvants elicits strong protective antibody responses.
Tierney R; Beignon AS; Rappuoli R; Muller S; Sesardic D; Partidos CD
J Infect Dis; 2003 Sep; 188(5):753-8. PubMed ID: 12934192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
